跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VIRAMUNE nevirapine (as hemihydrate) 50mg/5mL oral suspension bottle - TGA Drug Approval Details
Approvals
/
TGA
/
VIRAMUNE nevirapine (as hemihydrate) 50mg/5mL oral suspension bottle
Approved
STANDARD
VIRAMUNE nevirapine (as hemihydrate) 50mg/5mL oral suspension bottle
Boehringer Ingelheim Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
798a00e83275e16d
Company
Boehringer Ingelheim Pty Ltd
Type
Standard
Approval Details
Approval Id
798a00e83275e16d
Product Name
VIRAMUNE nevirapine (as hemihydrate) 50mg/5mL oral suspension bottle
Artg Id
72099
Artg Name
VIRAMUNE nevirapine (as hemihydrate) 50mg/5mL oral suspension bottle
Sponsor
Boehringer Ingelheim Pty Ltd
Company Detail Path
/organization/boehringer-ingelheim-pty-ltd
Artg Date
2000-08-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/a021202e5fd62be05bc975290874eceb.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/27c87710f64004f4becddfbbc63d538c.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
798a00e83275e16d
Type
Standard
Back to TGA Approvals